AstraZeneca Share Holder Equity 1992-2025 | AZN
AstraZeneca share holder equity from 1992 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- AstraZeneca share holder equity for the quarter ending June 30, 2025 was $44.810B, a 13.16% increase year-over-year.
- AstraZeneca share holder equity for 2024 was $40.871B, a 4.35% increase from 2023.
- AstraZeneca share holder equity for 2023 was $39.166B, a 5.69% increase from 2022.
- AstraZeneca share holder equity for 2022 was $37.058B, a 5.67% decline from 2021.
| AstraZeneca Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $40,871 |
| 2023 | $39,166 |
| 2022 | $37,058 |
| 2021 | $39,287 |
| 2020 | $15,638 |
| 2019 | $14,596 |
| 2018 | $14,044 |
| 2017 | $16,642 |
| 2016 | $16,669 |
| 2015 | $18,509 |
| 2014 | $19,646 |
| 2013 | $23,253 |
| 2012 | $23,946 |
| 2011 | $23,466 |
| 2010 | $23,410 |
| 2009 | $20,821 |
| 2008 | $2,989 |
| 2007 | $14,778 |
| 2006 | $15,304 |
| 2005 | $13,597 |
| 2004 | $14,519 |
| 2003 | $13,178 |
| 2002 | $11,172 |
| 2001 | $9,822 |
| 2000 | $9,542 |
| 1999 | $11,555 |
| 1998 | $4,169 |
| 1997 | $3,541 |
| 1996 | |